This firm is looking to leverage cannabinoids’ full potential to improve patient outcomes and contribute to global health initiatives. News of a submission for two patents for cancer care has sent shares up in Monday trade.
Cannabis Bioscience International Holdings (OTCMKTS: CBIH) announced in a press release today that it had submitted an inaugural pair of patents for legal review and subsequent registrations, focusing on novel treatment methodologies for breast and pancreatic cancers.
The firm’s dedicated scientific team has invested countless hours in research, culminating in the development of innovative treatment approaches specifically designed to tackle breast and pancreatic cancers. CBIH aims to accelerate the pace of innovation by submitting an additional 3 to 4 patents per month for the rest of 2024. Top priorities include patents related to the treatment of herpes zoster, knee osteoarthritis, and Alzheimer’s disease,…
